搜索





搜索





市场行情
/
股票
/
knsa
/

Kiniksa Pharmaceuticals International PLC

KNSA

添加自选

79.150USD

+15.615+24.58%

收盘 07-28 16:00（美东）报价延迟15分钟

6.04B总市值

81.35市盈率 TTM

Kiniksa Pharmaceuticals International PLC

79.150

+15.615+24.58%

概览

财务

分析

公司

财务摘要利润表资产负债表现金流量表

KNSA 利润表

您可以在这里找到Kiniksa Pharmaceuticals International PLC的年度或季度收入报告，以深入了解Kiniksa Pharmaceuticals International PLC的运营、管理效率和表现。

单季报

单季报+年报

单季报

年报

YOY

隐藏空白行

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

FY2018Q2

FY2018Q1

FY2017Q4

FY2017Q3

FY2017Q2

FY2017Q1

营业总收入

55.36%243.60M

55.51%214.27M

64.95%202.13M

61.17%180.85M

44.34%156.80M

72.54%137.78M

46.93%122.54M

67.37%112.21M

51.99%108.63M

65.18%79.86M

34.76%83.39M

-32.37%67.05M

164.99%71.47M

50.19%48.34M

230.14%61.88M

719.64%99.14M

250.10%26.97M

--32.19M

--18.75M

--12.10M

--7.70M

----

营业收入

55.36%243.60M

55.51%214.27M

64.95%202.13M

61.17%180.85M

44.34%156.80M

72.54%137.78M

46.93%122.54M

67.37%112.21M

51.99%108.63M

65.18%79.86M

34.76%83.39M

-32.37%67.05M

164.99%71.47M

50.19%48.34M

230.14%61.88M

719.64%99.14M

250.10%26.97M

--32.19M

--18.75M

--12.10M

--7.70M

----

主营业务成本

26.71%23.57M

16.39%20.80M

17.04%20.95M

0.74%20.26M

50.97%18.60M

68.84%17.87M

86.73%17.90M

121.27%20.11M

60.05%12.32M

50.41%10.58M

42.83%9.58M

31.01%9.09M

53.09%7.70M

66.77%7.04M

73.52%6.71M

150.70%6.94M

103.93%5.03M

--4.22M

--3.87M

--2.77M

--2.47M

----

营业费用

58.38%216.41M

48.58%185.00M

28.57%182.36M

28.69%156.83M

25.65%136.64M

29.16%124.51M

70.24%141.84M

56.30%121.87M

45.72%108.75M

61.91%96.40M

49.21%83.31M

47.89%77.97M

61.04%74.63M

7.27%59.54M

1.75%55.84M

23.29%52.72M

-3.98%46.34M

12.63%55.51M

3.74%54.88M

-1.06%42.76M

51.47%48.26M

67.70%49.28M

62.36%52.90M

41.95%43.22M

-18.91%31.86M

-56.56%29.39M

-26.18%32.58M

16.39%30.45M

82.51%39.29M

314.00%67.65M

34.92%44.13M

60.99%26.16M

88.97%21.53M

223.69%16.34M

--32.71M

--16.25M

--11.39M

--5.05M

研发费用

118.09%40.90M

42.17%27.48M

-1.72%34.61M

-7.26%24.17M

-21.92%18.75M

-26.62%19.32M

75.62%35.22M

52.33%26.06M

1.05%24.02M

73.57%26.33M

39.35%20.05M

3.77%17.11M

72.25%23.77M

-27.12%15.17M

-47.54%14.39M

-14.30%16.48M

-42.38%13.80M

-27.42%20.82M

-26.65%27.43M

-38.78%19.24M

7.26%23.95M

37.23%28.68M

63.41%37.40M

42.72%31.42M

-27.63%22.32M

-64.73%20.90M

-36.64%22.89M

6.64%22.01M

79.35%30.85M

369.14%59.25M

20.68%36.12M

47.37%20.64M

85.50%17.20M

301.59%12.63M

--29.93M

--14.01M

--9.27M

--3.15M

折旧摊销及损耗

----

35.65%468.00K

16.75%467.00K

-3.76%384.00K

-16.74%358.00K

-25.97%345.00K

-25.93%400.00K

-33.83%399.00K

-28.57%430.00K

-21.81%466.00K

-10.30%540.00K

22.31%603.00K

-7.53%602.00K

-9.15%596.00K

-9.88%602.00K

-25.08%493.00K

-9.21%651.00K

110.26%656.00K

17.81%668.00K

1.39%658.00K

20.50%717.00K

-47.47%312.00K

0.18%567.00K

24.09%649.00K

17.13%595.00K

26.11%594.00K

122.83%566.00K

4258.33%523.00K

4133.33%508.00K

5787.50%471.00K

3075.00%254.00K

50.00%12.00K

100.00%12.00K

33.33%8.00K

--8.00K

--6.00K

其他营业费用

68.01%88.07M

72.59%75.58M

45.32%70.03M

116.01%63.31M

74.65%52.42M

110.52%43.79M

184.49%48.19M

69.30%29.31M

114.60%30.01M

150.98%20.80M

125.19%16.94M

274.45%17.31M

280.88%13.99M

0.41%8.29M

800.84%7.52M

--4.62M

--3.67M

--8.25M

--835.00K

----

营业利润

34.89%27.19M

120.52%29.27M

202.43%19.77M

348.72%24.02M

17330.77%20.16M

180.23%13.27M

-23925.93%-19.30M

11.61%-9.66M

96.29%-117.00K

-47.75%-16.54M

-98.66%81.00K

-123.54%-10.93M

83.72%-3.15M

51.99%-11.20M

116.74%6.05M

251.35%46.41M

52.24%-19.37M

52.68%-23.32M

31.70%-36.13M

29.04%-30.67M

-27.29%-40.55M

-67.70%-49.28M

-62.36%-52.90M

-41.95%-43.22M

18.91%-31.86M

56.56%-29.39M

26.18%-32.58M

-16.39%-30.45M

-82.51%-39.29M

-314.00%-67.65M

-34.92%-44.13M

-60.99%-26.16M

-88.97%-21.53M

-223.69%-16.34M

---32.71M

---16.25M

---11.39M

---5.05M

净非营业利息收入（费用）

利息收入

45.42%3.95M

48.89%3.41M

50.91%3.50M

27.64%3.14M

12.23%2.72M

1.19%2.29M

-2.07%2.32M

1.19%2.46M

26.42%2.42M

23.69%2.27M

198.36%2.37M

654.04%2.43M

1759.22%1.92M

5288.24%1.83M

931.17%794.00K

6340.00%322.00K

1616.67%103.00K

277.78%34.00K

156.67%77.00K

-89.80%5.00K

-97.74%6.00K

-98.86%9.00K

-97.35%30.00K

-96.46%49.00K

-84.57%266.00K

-56.38%789.00K

-34.57%1.13M

-14.55%1.39M

61.73%1.72M

493.11%1.81M

1198.50%1.73M

859.76%1.62M

596.73%1.07M

312.16%305.00K

--133.00K

--169.00K

--153.00K

--74.00K

税前利润

36.14%31.14M

109.96%32.68M

237.05%23.27M

477.13%27.16M

892.93%22.88M

209.03%15.56M

-793.02%-16.98M

15.27%-7.20M

285.96%2.30M

-52.46%-14.28M

-64.19%2.45M

-118.19%-8.50M

93.57%-1.24M

59.79%-9.36M

118.97%6.84M

252.42%46.73M

52.49%-19.27M

52.74%-23.29M

31.80%-36.05M

28.97%-30.66M

-28.34%-40.55M

-72.30%-49.27M

-68.10%-52.87M

-48.55%-43.17M

15.90%-31.59M

56.56%-28.60M

25.84%-31.45M

-18.43%-29.06M

-83.59%-37.56M

-310.59%-65.84M

-30.17%-42.41M

-52.59%-24.54M

-82.05%-20.46M

-222.38%-16.04M

---32.58M

---16.08M

---11.24M

---4.97M

所得税

65.99%8.37M

43.60%10.09M

212.10%9.07M

58.81%8.72M

-18.79%5.04M

104.96%7.03M

64.49%-8.09M

2.54%5.49M

138.32%6.21M

17.96%3.43M

-1057.44%-22.79M

103.02%5.36M

-2364.11%-16.21M

50.96%2.91M

753.05%2.38M

-150203.39%-177.36M

-29.39%716.00K

816.67%1.93M

-64.64%279.00K

-117.69%-118.00K

-82.74%1.01M

109.64%210.00K

128.03%789.00K

133.32%667.00K

1670.86%5.88M

-12717.65%-2.18M

101.16%346.00K

-1428.24%-2.00M

-85.15%-374.00K

67.92%-17.00K

218.52%172.00K

-156.86%-131.00K

-461.11%-202.00K

-60.61%-53.00K

--54.00K

---51.00K

---36.00K

---33.00K

除税后利润

27.70%22.77M

164.57%22.59M

259.75%14.20M

245.24%18.43M

556.29%17.83M

148.23%8.54M

-135.22%-8.89M

8.39%-12.69M

-126.10%-3.91M

-44.29%-17.70M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

49.05%-25.21M

32.29%-36.33M

30.32%-30.54M

-10.93%-41.56M

-87.30%-49.48M

-68.75%-53.66M

-62.01%-43.84M

-0.75%-37.47M

59.86%-26.42M

25.32%-31.80M

-10.87%-27.06M

-83.58%-37.19M

-311.84%-65.82M

-30.49%-42.58M

-52.26%-24.41M

-80.84%-20.26M

-223.46%-15.98M

---32.63M

---16.03M

---11.20M

---4.94M

持续经营利润

42.62%25.43M

164.57%22.59M

259.75%14.20M

245.24%18.43M

556.29%17.83M

148.23%8.54M

-135.22%-8.89M

8.39%-12.69M

-126.10%-3.91M

-44.29%-17.70M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

49.05%-25.21M

32.29%-36.33M

30.32%-30.54M

-10.93%-41.56M

-87.30%-49.48M

-68.75%-53.66M

-62.01%-43.84M

-0.75%-37.47M

59.86%-26.42M

25.32%-31.80M

-10.87%-27.06M

-83.58%-37.19M

-311.84%-65.82M

-30.49%-42.58M

-52.26%-24.41M

-80.84%-20.26M

-223.46%-15.98M

---32.63M

---16.03M

---11.20M

---4.94M

反常净利润

----

---69.00K

----

其他净损益

--2.66M

----

归属于母公司的净利润

42.62%25.43M

164.57%22.59M

259.75%14.20M

245.24%18.43M

556.29%17.83M

148.23%8.54M

-135.22%-8.89M

8.39%-12.69M

-126.10%-3.91M

-44.29%-17.70M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

49.05%-25.21M

32.29%-36.33M

30.32%-30.54M

-10.93%-41.56M

-87.30%-49.48M

-68.75%-53.66M

-62.01%-43.84M

-0.75%-37.47M

59.86%-26.42M

25.32%-31.80M

-10.87%-27.06M

-83.58%-37.19M

-311.84%-65.82M

-30.21%-42.58M

-52.26%-24.41M

-80.84%-20.26M

-223.46%-15.98M

---32.70M

---16.03M

---11.20M

---4.94M

归属于普通股东的净利润

42.62%25.43M

164.57%22.59M

259.75%14.20M

245.24%18.43M

556.29%17.83M

148.23%8.54M

-135.22%-8.89M

8.39%-12.69M

-126.10%-3.91M

-44.29%-17.70M

465.73%25.24M

-106.18%-13.86M

174.93%14.97M

51.33%-12.27M

112.28%4.46M

833.67%224.09M

51.93%-19.98M

49.05%-25.21M

32.29%-36.33M

30.32%-30.54M

-10.93%-41.56M

-87.30%-49.48M

-68.75%-53.66M

-62.01%-43.84M

-0.75%-37.47M

59.86%-26.42M

25.32%-31.80M

-10.87%-27.06M

-83.58%-37.19M

-311.84%-65.82M

-30.21%-42.58M

-52.26%-24.41M

-80.84%-20.26M

-223.46%-15.98M

---32.70M

---16.03M

---11.20M

---4.94M

基本每股收益

35.01%0.33

151.20%0.30

252.05%0.19

239.43%0.25

541.17%0.24

146.89%0.12

-134.27%-0.12

10.35%-0.18

-125.70%-0.06

-42.49%-0.25

459.63%0.36

-106.12%-0.20

174.26%0.21

51.76%-0.18

112.16%0.06

825.41%3.23

52.55%-0.29

49.69%-0.36

33.14%-0.53

33.07%-0.44

6.07%-0.61

-51.78%-0.72

-36.02%-0.79

-34.68%-0.66

5.23%-0.65

62.45%-0.48

32.54%-0.58

0.00%-0.49

-66.66%-0.68

-285.45%-1.27

-27.18%-0.86

-52.26%-0.49

-80.84%-0.41

-223.46%-0.33

---0.68

---0.32

---0.23

---0.10

稀释每股收益

33.29%0.30

140.77%0.27

241.19%0.17

230.17%0.23

515.68%0.23

144.74%0.11

-137.90%-0.12

10.35%-0.18

-126.33%-0.06

-42.49%-0.25

414.76%0.32

-106.21%-0.20

172.48%0.21

51.76%-0.18

111.96%0.06

814.03%3.18

52.55%-0.29

49.69%-0.36

33.14%-0.53

33.07%-0.44

6.07%-0.61

-51.78%-0.72

-36.02%-0.79

-34.68%-0.66

5.23%-0.65

62.45%-0.48

32.54%-0.58

0.00%-0.49

-66.66%-0.68

-285.45%-1.27

-27.18%-0.86

-52.26%-0.49

-80.84%-0.41

-223.46%-0.33

---0.68

---0.32

---0.23

---0.10

每股派息

----

--0.00

货币单位

--USD

审计意见

----

常见问题

如何在 TradingKey 上查看 Kiniksa Pharmaceuticals International PLC 的利润表？



先看总营收，再依次查看营收成本、毛利润、营业费用、营业利润、税前利润、净利润和每股收益（EPS）。营收反映公司的业务规模，而各项利润和利润率则体现公司能否有效地将营收转化为盈利。

季度利润表和年度利润表有什么区别？



季度利润表反映公司在一个为期三个月的财务季度内的经营表现，年度利润表则汇总整个财年的业绩。季度数据适合用于观察近期发展势头和季节性变化，年度数据则更适合评估长期增长、盈利能力和业务周期。

利润表页面中的同比是什么意思？



同比是指将某项财务指标与上年同期进行比较，例如将本季度营收与去年同一季度的营收进行对比。同比数据有助于投资者观察增长趋势，同时减少正常季节性变化对分析的影响。

分析 KNSA 股票时，哪些利润表指标最重要？



重要的指标包括营收增长、毛利润、毛利率、营业利润、营业利润率、净利润、每股收益、研发费用、销售及管理费用以及所得税费用。投资者通常会综合分析这些指标，以判断公司是否正在增长、有效控制成本并提升盈利能力。

Kiniksa Pharmaceuticals International PLC 财年末的营收是多少？



Kiniksa Pharmaceuticals International PLC 2025 财年营收为 677.56M，高于上一财年的423.24M。

Kiniksa Pharmaceuticals International PLC 最近一个季度的营收是多少？



Kiniksa Pharmaceuticals International PLC 最近一个季度的营收为 243.60M，同比增长 55.36%。

Kiniksa Pharmaceuticals International PLC 全年的净利润是多少？



Kiniksa Pharmaceuticals International PLC 2025 财年净利润为 59.01M。

Kiniksa Pharmaceuticals International PLC 上一季度的净利润是多少？



Kiniksa Pharmaceuticals International PLC 最近一个季度的净利润为 25.43M。

Kiniksa Pharmaceuticals International PLC 年度营业利润是多少？



Kiniksa Pharmaceuticals International PLC 2025 财年的营业利润为 77.22M。

每股收益与利润表有什么关系？



每股收益（EPS）通常以净利润除以流通在外的股份数量计算，用于衡量公司平均每股创造的利润。分析 EPS 时，还应结合股本变化、利润率、现金流和估值指标进行综合判断。